OGRD Alliance Advances PLPC Multi-Asset Platform Following APHELAR Milestone, Expanding Licensing and Strategic Capital Frameworks
DUBAI, UAE, October 6th, 2026, FinanceWire
Microdomain Science connects differentiated assets across personalized immuno-oncology, acellular biotechnology, MedTech and precision nutrition as OGRD Alliance expands international market access, asset-specific licensing, commercialization and strategic-capital initiatives.
OGRD Alliance L.L.C-FZ announced a new phase in the international development of PLPC Platform following the public listing with Singapore’s Health Sciences Authority (HSA) of the APHELAR Family as Class A medical devices, with OGRD Alliance identified as Product Owner.
The milestone adds a defined MedTech pathway to PLPC Platform, extending a broader multi-asset architecture designed to support distinct scientific, regulatory and commercial development routes.
Singapore pr...
